Last reviewed · How we verify
Manexin (mannite hexanitrate)
Manexin (generic name: mannite hexanitrate) is a drug. It is currently in unknown development.
Manexin works by binding to specific biological molecules to produce a therapeutic effect.
Manexin is a small molecule with the synonyms D-MANNITOL HEXANITRATE, HEXANITRATE DE MANNITOL, and others. Its modality is classified as a small molecule.
At a glance
| Generic name | mannite hexanitrate |
|---|---|
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine Manexin as a key that fits into a specific lock in the body. When it binds to that lock, it can turn on or off certain processes that help to treat a particular disease or condition. This is a simplified way of understanding how small molecules like Manexin work to produce their effects.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Manexin CI brief — competitive landscape report
- Manexin updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Manexin
What is Manexin?
How does Manexin work?
What is the generic name of Manexin?
What development phase is Manexin in?
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing